MIRIBUNG Medical SRL
MIRIBUNG Medical reported total assets of 259,589 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Dec 2025).
The score of MIRIBUNG Medical shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -29 % Total assets +15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MIRIBUNG Medical's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 153,384 € | ||||
| Equity | 153,715 € | ||||
| Cash | 104,376 € | ||||
| EBITDA | 236,747 € | ||||
| Total assets | 259,589 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 12 Dec 2025
- Year ended 30 Jun 2024filed on 09 Dec 2024
- Year ended 30 Jun 2023filed on 07 Dec 2023
- Year ended 30 Jun 2022filed on 12 Jan 2023
- Year ended 30 Jun 2021filed on 07 Dec 2021
MIRIBUNG Medical's financial analysis
- Solvency59.2%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MIRIBUNG Medical
MIRIBUNG Medical's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0837.434.652
- VAT number
- BE0837434652
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 23 Jun 2011
- Registered office
- 4730 Raeren
- Latest accounts
- 2025 · filed on 12 Dec 2025
- Activity
- Medical specialists activities (NACE 86220)
MIRIBUNG Medical (SRL) has been based in Raeren since 2011, active in: medical specialists activities. For 2025, it reports a net profit of 153,384 € and equity of 153,715 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MIRIBUNG Medical
Companies in the same business, of comparable size and area, outside its group.
- Societe Medicale Annick Jadot Medical specialists activities Liège · balance sheet 257,141 €
- Dr. Dries Knaeps Medical specialists activities Turnhout · balance sheet 259,638 €
- Dokter Elise Pannier Anesthesist Medical specialists activities Sint-Niklaas · balance sheet 259,662 €
- Anesthésie Dr Thomas Vanye Medical specialists activities Genappe · balance sheet 259,685 €
- C.O.A.L. Medical specialists activities Anderlecht · balance sheet 259,462 €
- Piessens Aesthetics Medical specialists activities Antwerp · balance sheet 259,861 €
- Kinderarts Vanlede Koen Medical specialists activities Temse · balance sheet 259,205 €
- SP Medical specialists activities Nazareth-De Pinte · balance sheet 259,137 €
Frequently asked questions about MIRIBUNG Medical
What is the revenue of MIRIBUNG Medical?
MIRIBUNG Medical files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MIRIBUNG Medical?
In Belgium, the VAT number is the company number prefixed with BE: BE0837434652 for MIRIBUNG Medical, if the company is VAT-registered. Its company number (CBE) is 0837.434.652.
Where is the registered office of MIRIBUNG Medical?
According to the CBE register, the registered office of MIRIBUNG Medical is in 4730 Raeren.
What is the equity of MIRIBUNG Medical?
At the close of the 2025 financial year, the equity of MIRIBUNG Medical amounts to 153,715 €, a solvency of 59.2% of total assets.
Who manages MIRIBUNG Medical?
The register lists 2 active mandates at MIRIBUNG Medical. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MIRIBUNG Medical
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →